External Oblique Intercostal Block Versus Erector Spinae Plane Block on Postoperative Pain in Laparoscopic Radical Gastrectomy
Effects of Ultrasound-guided External Oblique Intercostal Block Versus Erector Spinae Plane Block on Postoperative Pain in Laparoscopic Radical Gastrectomy
1 other identifier
interventional
184
1 country
1
Brief Summary
Postoperative pain is highly prevalent following laparoscopic radical gastrectomy. Although the erector spinae plane block (ESPB) can effectively alleviate this pain, it still has many limitations. The external oblique intercostal plane block (EOIB) is a novel nerve block technique that may provide well postoperative analgesia for upper abdominal surgery. Therefore, this study employs a non-inferiority randomized controlled trial design to verify that the analgesic effect of EOIB is not inferior to that of ESPB, thereby offering more options for regional analgesia strategies in laparoscopic radical gastrectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable postoperative-pain
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 1, 2026
CompletedFirst Posted
Study publicly available on registry
February 9, 2026
CompletedStudy Start
First participant enrolled
March 12, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 6, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 9, 2027
March 16, 2026
February 1, 2026
11 months
February 1, 2026
March 12, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Cumulative opioid consumption within 24 hours postoperatively
Cumulative opioid consumption within 24 hours postoperatively. Conversion to morphine equivalent dose (mg)
24 hours after surgery
Secondary Outcomes (3)
Pain Intensity
2, 6, 12, 24, 48, and 72 hours postoperatively
Quality of Recovery
24,48,72 hours after surgery
sleep quality
24,48,72 hours after surgery
Study Arms (2)
ESPB
EXPERIMENTALAfter patients entering the operating room, an intravenous line was established, and Erector Spinae Plane Block was performed under ultrasound guidance.
EOIB
EXPERIMENTALAfter patients entering the operating room, an intravenous line was established, and External Oblique Intercostal Plane Block was performed under ultrasound guidance.
Interventions
With the patient in the supine position, a high-frequency linear array probe (6-15 MHz) is used to perform a sagittal parasagittal oblique scan at the level of the 6th rib, between the right anterior axillary line and midclavicular line. The external oblique muscle, intercostal muscles, and ribs are identified. Using an in-plane technique, a 21G, 100mm block needle is inserted from a superomedial to inferolateral direction, with the needle tip positioned in the plane between the external oblique muscle and the intercostal muscles at the caudal edge of the 6th rib. 30ml of 0.375% ropivacaine is injected on each side, for a bilateral administration.
With the patient in the lateral decubitus position (surgical side up), a low-frequency convex array probe (2-5 MHz) is used to perform a sagittal scan approximately 2-3 cm lateral to the spinous process of T8 or T9. The transverse process and the erector spinae muscle are identified. Using an out-of-plane technique, a 21G, 100mm block needle is advanced until contact is made with the transverse process. The needle is then withdrawn 1-2 mm to position its tip within the fascial plane deep to the erector spinae muscle and superficial to the transverse process. 30 ml of 0.375% ropivacaine is injected on each side, for a bilateral administration.
Eligibility Criteria
You may qualify if:
- Patients aged over 18 years
- Classified as ASA I-III
- Scheduled for elective laparoscopic radical gastrectomy under general anesthesia
- Voluntarily participated and provided written informed consent.
You may not qualify if:
- Chronic opioid dependence or prior use of analgesic medications for \>3 months;
- Inability to communicate due to severe dementia, language barriers, or terminal illness;
- History of central and/or peripheral nervous system disorders;
- Severe renal insufficiency (serum creatinine \>442 μmol/L or requiring renal replacement therapy) or severe hepatic insufficiency (Child-Pugh class C);
- Allergy to local anesthetics.
- Expected to be transferred to ICU after surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
General hospital of Ningxia medical university
Yinchuan, Ningxia, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Xinli Ni, Doctoral
86-951-674-3252
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- On the day of surgery, after the induction of general anesthesia, the study coordinator opened the corresponding envelope in the order of recruitment. Patients were randomly assigned to receive either EOIB or ESPB, which was performed preoperatively by an experienced anesthesiologist. The anesthesiologist was aware of the intervention, but all patients, data investigator and postoperative follow-up remained blinded to group assignment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 1, 2026
First Posted
February 9, 2026
Study Start
March 12, 2026
Primary Completion (Estimated)
February 6, 2027
Study Completion (Estimated)
February 9, 2027
Last Updated
March 16, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share